• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION LONGFORD ARCHITECT TOTAL B-HCG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION LONGFORD ARCHITECT TOTAL B-HCG Back to Search Results
Model Number 7K78-25
Device Problem False Positive Result (1227)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/23/2020
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.There was no additional patient information provided.
 
Event Description
The customer stated that a false positive architect total bhcg result of 431.74 iu/l was generated for a patient (sid (b)(6)) on (b)(6) 2020 and was questioned by the physician.The same sample retested negative at <1.2 iu/l.No adverse impact to patient management was reported.
 
Manufacturer Narrative
The complaint investigation for false positive results for one patient when tested with the architect total b-hcg assay included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labelling review, device history record review, field data review and inhouse testing of retained kits with the complaint lot number.Trending review determined no adverse trend for the product.Device history record review did not identify any non-conformances or deviations with the likely cause lot.Inhouse testing determined that the specificity performance is not negatively impacted.The overall performance of architect total b-hcg reagents in the field was reviewed using data gathered via abbottlink from customers worldwide and suggested that the performance of the lot is acceptable.Based on our investigation, we have determined that there is no general issue with the architect total b-hcg reagent lot identified in this complaint.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT TOTAL B-HCG
Type of Device
B-HCG
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION LONGFORD
lisnamuck
co. longford
longford NA
EI  NA
MDR Report Key10286024
MDR Text Key203328954
Report Number3005094123-2020-00149
Device Sequence Number1
Product Code DHA
UDI-Device Identifier00380740014964
UDI-Public00380740014964
Combination Product (y/n)N
PMA/PMN Number
K983424
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 09/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/16/2020
Device Model Number7K78-25
Device Catalogue Number07K78-25
Device Lot Number06106UI00
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/22/2020
Initial Date FDA Received07/16/2020
Supplement Dates Manufacturer Received09/10/2020
Supplement Dates FDA Received09/16/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR ANALYZER, LIST 03M74-02; ARCHITECT I2000SR ANALYZER, LIST 03M74-02; SERIAL (B)(4); SERIAL (B)(4)
-
-